Conducting gene therapy clinical trials based on natural history studies for inherited retinal diseases in Chinese population
Open Access
- 15 October 2022
- journal article
- editorial
- Published by Elsevier in Advances in Ophthalmology Practice and Research
- Vol. 3 (1) , 6-8
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Early and late stage gene therapy interventions for inherited retinal degenerationsProgress in Retinal and Eye Research, 2022
- Choosing Outcome Measures and Assessing Efficacy of Therapeutic Interventions in Inherited Retinal Diseases: The Importance of Natural History StudiesInternational Ophthalmology Clinics, 2021
- Gene TherapyNew England Journal of Medicine, 2019
- Detailed clinical characterisation, unique features and natural history of autosomal recessive RDH12-associated retinal degenerationBritish Journal of Ophthalmology, 2019
- The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 GeneAmerican Journal of Ophthalmology, 2019
- Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trialThe Lancet, 2017